← Back to Search

Cognitive-Behavior Therapy for Autism Spectrum Disorder (TALAA Trial)

N/A
Waitlist Available
Led By Adam Lewin, Ph.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 16 weeks of treatment
Awards & highlights

TALAA Trial Summary

This study is evaluating whether a new treatment approach for anxiety may be effective for individuals with autism spectrum disorder.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

TALAA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 16 weeks of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 16 weeks of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Secondary outcome measures
Change from Baseline in anxiety severity on the Clinical Global Impressions Scale after 16 weeks of treatment.

TALAA Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cognitive-Behavior TherapyExperimental Treatment1 Intervention
This consists of 16 weekly sessions up to 90 minutes each that helps the participant learn to cope with anxiety by facing fears, thinking more logically, and calming oneself.
Group II: Treatment as UsualPlacebo Group1 Intervention
Participants randomized to this condition will wait for a period of 16 weeks before receiving treatment in the context of the study. During this time, youth may receive psychotherapy and/or initiate or change current psychiatric medication (if applicable).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive-Behavior Therapy
2008
Completed Phase 4
~220

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
407 Previous Clinical Trials
186,765 Total Patients Enrolled
12 Trials studying Autism Spectrum Disorder
983 Patients Enrolled for Autism Spectrum Disorder
Johns Hopkins All Children's HospitalOTHER
43 Previous Clinical Trials
5,007,495 Total Patients Enrolled
Adam Lewin, Ph.D.Principal InvestigatorUniversity of South Florida
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Treatment of Anxiety in Late Adolescents With Autism
2017. "Treatment of Anxiety in Late Adolescents With Autism". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02977962.
All > Anxiety
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top